Dataset from PHASE 1/2 STUDY OF PF-06463922 (AN ALK/ROS1 TYROSINE KINASE INHIBITOR) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING SPECIFIC MOLECULAR ALTERATIONS
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008328
下载链接
链接失效反馈官方服务：
资源简介：
Phase 1 and 2 trial to study the safety, pharmacokinetics, pharmacodynamics, patient reported
outcomes and efficacy of PF-06463922 in ALK + advanced non-small cell lung cancer patients
and ROS1+ advanced non small cell lung cancer patients .
创建时间：
2025-03-09
